reparerx.com (RPTX): Utang marang Ekuitas

Logo korporat perusahaan Repare Therapeutics Inc (RPTX)

Repare Therapeutics (RPTX) is a biopharmaceutical leader developing cancer treatment methods through synthetic lethality and CRISPR powered by AI. The company is engaged in a fierce battle with industry behemoths for access to clinical cohorts. This chart of stock quotes demonstrates a total debt-to-equity ratio of 0.00. High demand for resistant tumor therapies is driving the growth of its partner network.

RPTX: Rasio Total Utang marang Ekuitas Repare Therapeutics Inc. 04.07.2022 - 07.02.2026

Rincian metrik komprehensif lan analitis Repare Therapeutics Inc (RPTX)

- rega lan prakiraan konsensus rega:
Bagan rega Repare Therapeutics Inc.|RPTX - Rata-rata rega prakiraan
- data kapitalisasi bursa:
Nilai pasar Repare Therapeutics|RPTX - Nilai Bisnis
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Repare Therapeutics|RPTX - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku reparerx.com|RPTX - Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Repare Therapeutics|RPTX - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Repare Therapeutics|RPTX - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Repare Therapeutics|RPTX - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan Repare Therapeutics|Indikator likuiditas cepet reparerx.com
- informasi bathi lan kelipatan valuasi:
RPTX - Bathi pungkasan
Analisis fundamental perusahaan:Repare Therapeutics Inc., RPTX
Barang utama Repare Therapeutics

To minimize investment risks, it is critical to assess the balance sheet stability of Repare Therapeutics (RPTX), whose liquidity is currently supported by payments from strategic partners in oncology development. By analyzing the business's leverage ratio, an investor determines the proportion of borrowed funds relative to equity, which clarifies the company's level of dependence on creditors and its ability to fund future clinical trials without excessive debt burden.

Pesaing Repare Therapeutics (RPTX)

Utang marang Ekuitas Genmab|Utang marang Modal Exelixis Inc EXEL|Utang marang Ekuitas Nuvalent Corp (NUVL)|Kymera Corp - Rasio Utang marang Ekuitas|Total Utang marang Modal IDYA (IDEAYA Biosciences)|ELVN - Rasio Total Utang marang Ekuitas|ORIC - Utang marang Ekuitas|Utang marang Modal Relay Therapeutics Inc|Nurix Pharma (NRIX) - Utang marang Ekuitas|TYRA (Tyra Corp) - Utang marang Ekuitas|Utang marang Ekuitas Verastem, Inc.|Utang marang Modal monterosatx.com GLUE|Total Utang marang Modal CGEM|Immuneering Corp (IMRX) - Rasio Utang marang Modal|C4 Tx - Rasio Total Utang marang Ekuitas|Black Diamond Therapeutics, Inc (BDTX) - Utang marang Modal|PMVP: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi KPTI (Karyopharm Therapeutics)|PPCB (propanc.com) - Rasio Total Utang marang Ekuitas|BGMS: Utang Agregat marang Modal|AADI (Aadi Bioscience Inc) - Total Utang marang Modal|Total Utang marang Modal Aileron|Utang marang Ekuitas Blueprint Medicines (BPMC)|GLYC (glycomimetics.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SWTX (SpringWorks Therapeutics, Inc.)